BRAF and thyroid gland undifferentiated (anaplastic) carcinoma: Compared with the negative control group and BRAF WT overexpression, the loss of TMRE was significantly delayed in papillary and anaplastic thyroid cancer cells with BRAF V600E overexpression (Figures 5D,E and 7A,C).